PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Pre-Mkt 05-12 09:16:22 EDT

26.45

+1.05

+4.13%

盘前26.40

-0.05-0.19%

09:10 EDT

High27.81	Low25.00	Vol2.36M
Open25.36	D1 Closing25.40	Amplitude11.06%
Mkt Cap1.51B	Tradable Cap1.42B	Total Shares56.91M
T/O62.90M	T/O Rate4.41%	Tradable Shares53.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":26.45,"timestamp":1778529600000,"preClose":25.4,"halted":0,"volume":2364039,"hourTrading":{"tag":"盘前","latestPrice":26.4,"preClose":26.45,"latestTime":"09:10 EDT","volume":185,"amount":4911.57018,"timestamp":1778591421302,"change":-0.05,"changeRate":-0.00189,"amplitude":0.006427},"delay":0,"changeRate":0.041338582677165385,"floatShares":53564164,"shares":56909414,"eps":-1.832336,"marketStatus":"Pre-Mkt","change":1.05,"latestTime":"05-12 09:16:22 EDT","open":25.36,"high":27.81,"low":25,"amount":62899638.159267,"amplitude":0.11063,"askPrice":27.18,"askSize":19,"bidPrice":25.38,"bidSize":94,"shortable":3,"etf":0,"ttmEps":-1.832336,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778592600000},"marketStatusCode":1,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":26.45,"preHourTrading":{"tag":"盘前","latestPrice":26.4,"preClose":26.45,"latestTime":"09:10 EDT","volume":185,"amount":4911.57018,"timestamp":1778591421302,"change":-0.05,"changeRate":-0.00189,"amplitude":0.006427},"postHourTrading":{"tag":"盘后","latestPrice":26.45,"preClose":26.45,"latestTime":"19:59 EDT","volume":13361,"amount":353372.15,"timestamp":1778543977130,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.0594281574589792,"impliedVol":0.4375,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/PRCT/wiki","defaultTab":"wiki","newsList":[{"id":"2634238237","title":"Should PROCEPT BioRobotics’ Reaffirmed 2026 Outlook Amid Wider Losses Require Action From PRCT Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634238237","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634238237?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:22","pubTimestamp":1778509367,"startTime":"0","endTime":"0","summary":"In April 2026, PROCEPT BioRobotics Corporation reported first-quarter 2026 results showing sales of US$83.13 million versus US$69.16 million a year earlier, alongside a wider net loss of US$31.64 million and basic loss per share of US$0.56.\nAt the same time, the company reaffirmed its full-year 2026 outlook, including expected revenue of US$390 million to US$410 million and a net loss range of US$78.50 million to US$91.50 million, underlining management’s confidence in its growth plans...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/should-procept-biorobotics-reaffirmed-2026-outlook-amid-wide","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/should-procept-biorobotics-reaffirmed-2026-outlook-amid-wide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT","BK4211","ISBC","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667391","title":"Procept BioRobotics EVP, CTO Barry Templin files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667391","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632667391?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:10","pubTimestamp":1777587048,"startTime":"0","endTime":"0","summary":"Procept BioRobotics EVP, Chief Technology Officer Barry L. Templin filed Form 3 on April 30, 2026, reporting 69,311 shares of common stock held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4jB3Kb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632650956","title":"Procept BioRobotics to present at Bank of America Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2632650956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632650956?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:10","pubTimestamp":1777579803,"startTime":"0","endTime":"0","summary":"Procept BioRobotics management will present at 2026 Bank of America Health Care Conference on May 12 in Las Vegas.Management is scheduled to present at 46th Annual William Blair Growth Stock Conference on June 2 in Chicago.Company will also take part in 2026 Truist Med-Tech Conference on June 16 in Boston.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL7NK4lt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","NDAQ","LU2129689431.USD","IE00BN0W2W23.USD","LU1496350171.SGD","LU0149725797.USD","LU0052756011.USD","LU0683600562.USD","BK4585","LU0234570918.USD","LU1880398471.USD","LU0310800965.SGD","LU0106831901.USD","LU1496350502.SGD","IE00B1BXHZ80.USD","LU0130518102.USD","LU1718418525.SGD","IE00B19Z3581.USD","LU0320765646.SGD","LU0980610538.SGD","IE00BGHQF748.EUR","LU1267930227.SGD","LU0170899867.USD","LU0306807586.USD","LU1069347547.HKD","BK4534","IE00BLSP4239.USD","LU0314104364.USD","LU1804176565.USD","LU2129689605.HKD","LU0640476718.USD","LU0477156953.USD","LU0648001328.SGD","LU0314106906.USD","BAC","IE00B19Z3B42.SGD","LU0130517989.USD","LU0203345920.USD","IE00BN0W2V16.EUR","PRCT","IE00B3QW5Z07.USD","IE0002270589.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","LU1201861249.SGD","LU1880398554.USD","IE00BBT3K403.USD","LU1363072403.SGD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632657437","title":"PROCEPT BioRobotics Price Target Raised to $35.00/Share From $28.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2632657437","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632657437?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:28","pubTimestamp":1777570080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2026 13:28 ET (17:28 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131971457","title":"Stock Track | PROCEPT BioRobotics Soars 11.56% in Night Session on Strong Q1 Earnings Beat and Upbeat Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1131971457","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131971457?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:31","pubTimestamp":1777523489,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corporation (PRCT) saw its stock price surge 11.56% in night session trading on Thursday, following the release of its first-quarter 2026 financial results after market close on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631457015","title":"Procept Biorobotics Corp : Piper Sandler Raises Target Price to $35 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2631457015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631457015?lang=en_us&edition=fundamental","pubTime":"2026-04-30 11:25","pubTimestamp":1777519502,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LU2324357040.USD","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631057577","title":"PROCEPT BioRobotics: Buy Rating Reaffirmed on Strong Q1 Performance and Multi‑Year Outlook, Price Target Unchanged at $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2631057577","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631057577?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:45","pubTimestamp":1777517136,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on PROCEPT BioRobotics, with a price target of $34.00. Josh Jen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/procept-biorobotics-buy-rating-reaffirmed-on-strong-q1-performance-and-multi‑year-outlook-price-target-unchanged-at-34-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/procept-biorobotics-buy-rating-reaffirmed-on-strong-q1-performance-and-multi‑year-outlook-price-target-unchanged-at-34-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631759425","title":"Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Alterity Therapeutics (OtherPRNAF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2631759425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631759425?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:00","pubTimestamp":1777507218,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT) and Alterity Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-alterity-therapeutics-otherprnaf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-alterity-therapeutics-otherprnaf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","XBI","BK4539","LENZ","BK4585","LU0029874061.USD","BK4588","LU2324357040.USD","BK4581","HCSG","BK4137","LU0128526141.USD","XLV","PRCT","LABU","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132941148","title":"Stock Track | PROCEPT BioRobotics Soars 15.15% After-Hours on Strong Q1 Earnings Beat and Upbeat Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1132941148","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132941148?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:38","pubTimestamp":1777495113,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corporation (PRCT) saw its stock price surge 15.15% in after-hours trading on Wednesday, following the release of its first-quarter 2026 financial results.The surgical robotics...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631526538","title":"Procept BioRobotics Q1 net loss widens 28% to $31.6 million; revenue rises 20% to $83.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631526538","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631526538?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:14","pubTimestamp":1777493679,"startTime":"0","endTime":"0","summary":"Procept BioRobotics posted a net loss of USD 31.6 million in first-quarter 2026, widening from a year earlier.Gross margin improved to about 65% from 64% a year earlier.Aquablation users completed about 12,200 U.S. procedures, up about 30%, while U.S. install base rose 40% to 765 systems.Procept maintained full-year 2026 revenue outlook of USD 390 million to USD 410 million, targeting U.S. procedure growth of 39% to 48%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL5w4skz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4588","SG9999014039.USD","BK4082","BK4112","IE00BN0W2V16.EUR","PRCT","NDAQ","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","LU2095319765.USD","LU2324357040.USD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120292152","title":"Stock Track | PROCEPT BioRobotics Plummets 7.43% Intraday on Q1 2026 Earnings Results and Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1120292152","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120292152?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:06","pubTimestamp":1777493212,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) experienced a sharp decline of 7.43% during intraday trading on Wednesday, as the market digested the company's latest financial updates.The movement coincided with the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352585","title":"PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352585","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631352585?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:04","pubTimestamp":1777493064,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.56) per share which met the analyst consensus estimate. This is a 24.44 percent decrease over losses of $(0.45) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52149536/procept-biorobotics-q1-eps-0-56-inline-sales-83-132m-beat-80-506m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631252327","title":"BRIEF-Procept Biorobotics Q1 Revenue USD 83.132 Million Vs. IBES Estimate USD 80.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631252327","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631252327?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:03","pubTimestamp":1777493025,"startTime":"0","endTime":"0","summary":"Apr 29  - Procept Biorobotics Q1 adjusted EBITDA USD -18.122 million vs. IBES estimate USD -18.7 million.outlook FY adjusted EBITDA USD -30 to -17 million vs. IBES estimate USD -30 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nPLXD14B6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631523228","title":"Procept Biorobotics Q1 EPS USD -0.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2631523228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631523228?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:03","pubTimestamp":1777492980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nPLXD14B6F:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631523226","title":"Procept Biorobotics Outlook FY Revenue Growth 27-33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631523226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631523226?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:03","pubTimestamp":1777492980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nPLXD14B6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631523740","title":"PROCEPT BioRobotics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2631523740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631523740?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:03","pubTimestamp":1777492980,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., April  29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transf","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3284216/0/en/PROCEPT-BioRobotics-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BPH","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630782735","title":"Procept BioRobotics files Form 3 for Chief Strat/Marketing Officer Pooja Sharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2630782735","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630782735?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:22","pubTimestamp":1777062146,"startTime":"0","endTime":"0","summary":"Procept BioRobotics Chief Strategy and Marketing Officer Pooja Sharma filed an initial Form 3 reporting 87,559 shares of common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL8G2HJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105048460","title":"Earning Preview: PROCEPT BioRobotics this quarter’s revenue is expected to increase by 22.57%, and institutional views are predominantly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1105048460","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105048460?lang=en_us&edition=fundamental","pubTime":"2026-04-23 13:11","pubTimestamp":1776921084,"startTime":"0","endTime":"0","summary":"Abstract PROCEPT BioRobotics will report its first‑quarter 2026 financial results Post Market on April 29, 2026; this preview outlines consensus expectations for revenue of 80.51 million US dollars,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: PROCEPT BioRobotics this quarter’s revenue is expected to increase by 22.57%, and institutional views are predominantly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629730220","title":"Procept BioRobotics announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2629730220","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629730220?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:14","pubTimestamp":1776892452,"startTime":"0","endTime":"0","summary":"Procept BioRobotics scheduled 2026 annual stockholders meeting for virtual format on June 9, 2026.Vote set on election of three Class II director nominees to terms running to 2029.Stockholders also to cast advisory vote on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLWj597:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4082","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627665612","title":"PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2627665612","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627665612?lang=en_us&edition=fundamental","pubTime":"2026-04-16 13:07","pubTimestamp":1776316068,"startTime":"0","endTime":"0","summary":"In the past quarter, PROCEPT BioRobotics reported strong third-quarter 2025 execution and issued fiscal 2026 revenue expectations of US$410 million to US$430 million, while management detailed organizational changes to accelerate new account launches and boost therapy awareness.\nBeyond the headline numbers, the company’s emphasis on improving procedure utilization to unlock longer-term value highlights how management is targeting deeper engagement within its existing customer base rather...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-75-after-raising-2026-revenue","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-75-after-raising-2026-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":0.0652},{"period":"1month","weight":0.1401},{"period":"3month","weight":-0.1169},{"period":"6month","weight":-0.1404},{"period":"1year","weight":-0.5021},{"period":"ytd","weight":-0.1592}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.079362},{"month":2,"riseRate":0.4,"avgChangeRate":0.005067},{"month":3,"riseRate":0.6,"avgChangeRate":0.037831},{"month":4,"riseRate":0.6,"avgChangeRate":0.00923},{"month":5,"riseRate":1,"avgChangeRate":0.125766},{"month":6,"riseRate":0.25,"avgChangeRate":-0.048608},{"month":7,"riseRate":0.5,"avgChangeRate":0.00614},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.2,"avgChangeRate":-0.059852}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}